ERBB2 and breast cancer: This approach was replicatedindependently and confirmed the earlier findings andsub-stratified BC tumours into basal-like, two luminallike,normal-like and ERB-B2 over-expressing cancers.This approach was further validated by similar sub-stratification results reported in another two independentstudies based on samples obtained from different patientpopulations.